Price Alert

IVERIC bio Inc. (ISEE)

NASDAQ: ISEE · Real-Time Price · USD

39.95

0.15 (0.38%)

At close: Jul 10, 2023, 10:00 PM

IVERIC bio Statistics

Share Statistics

IVERIC bio has 137.98M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	137.98M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	137.02M
Failed to Deliver (FTD) Shares	642
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 19.43M, so 0% of the outstanding shares have been sold short.

Short Interest	19.43M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.55

Valuation Ratios

The PE ratio is -14.75 and the forward PE ratio is null. IVERIC bio's PEG ratio is -0.5.

PE Ratio	-14.75
Forward PE	n/a
PS Ratio	0
Forward PS	n/a
PB Ratio	4.85
P/FCF Ratio	-15.75
PEG Ratio	-0.5

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for IVERIC bio.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.63, with a Debt / Equity ratio of 0.18.

Current Ratio	18.63
Quick Ratio	18.63
Debt / Equity	0.18
Debt / EBITDA	-0.51
Debt / FCF	-0.59
Interest Coverage	-83.88

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	$-1.08M
Employee Count	163
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	-9.47M
Effective Tax Rate	5.11%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 1.1, so IVERIC bio's price volatility has been higher than the market average.

Beta	1.1
52-Week Price Change	n/a
50-Day Moving Average	38.02
200-Day Moving Average	26.09
Relative Strength Index (RSI)	69.05
Average Volume (20 Days)	4,945,949

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-189.91M
Net Income	-175.75M
EBITDA	-192.28M
EBIT	-182.95M
Earnings Per Share (EPS)	-1.45

Full Income Statement

Balance Sheet

The company has 476.3M in cash and 97.77M in debt, giving a net cash position of 378.54M.

Cash & Cash Equivalents	476.3M
Total Debt	97.77M
Net Cash	378.54M
Retained Earnings	-864.81M
Total Assets	613.41M
Working Capital	572.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -163.77M and capital expenditures -736K, giving a free cash flow of -164.51M.

Operating Cash Flow	-163.77M
Capital Expenditures	-736K
Free Cash Flow	-164.51M
FCF Per Share	-1.36

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ISEE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for ISEE.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	22
Piotroski F-Score	1